
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Parexel and TriNetX have announced a strategic effort through which they will connect healthcare data to support the development of insights intended to accelerate the execution of clinical research. Working with Parexel’s strategic partner Datavant, the integrated offering will leverage Datavant’s privacy-protecting linking technology to connect Parexel’s study operations data with de-identified data from TriNetX’s network of global healthcare organizations.
For more information, click






